Company: IPSC
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001104659-25-037419
Chunk: 38

Company: Century Therapeutics, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 38
---
 |   |
| ​ | ​                                                              | ​                              | 3/7/2024(4)   | ​                                                                | ​          | ​ |                       ​ | ​ | ​ |                    ​ |             ​ | ​ |                                                     ​ |      ​ | ​ | ​                                                               |     ​ | ​ |  24,000 | ​          | ​ |  $24,240 | ​            | ​ |   |   |   |   |

(1) The market value is based on the closing stock price of $1.01 on December 31, 2024 (the last trading date in the 2024 fiscal year). (2) This option vests 25% on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject generally to the NEO’s continued employment with us. (3) This restricted stock unit vests 25% on December 4, 2024, and the remaining 75% vesting in 12 equal quarterly installments every February 15, May 15, August 15, November 15 thereafter, subject generally to the NEO’s continued employment with us. (4) This restricted stock unit vests 25% on the first anniversary of the grant date and the remaining 75% in 12 equal quarterly installments thereafter, subject generally to the NEO’s continued employment with us. (5) This option vests 25% on the first anniversary of the grant date and the remaining 75% in 36 equal monthly installments thereafter, subject generally to the NEO’s continued employment with us. (6) This option vests 25% on January 1, 2021 and the remaining 75% in 36 equal monthly installments thereafter, subject generally to the NEO’s continued employment with us. On January 15, 2021, Dr. Russotti utilized the early exercise feature of her stock option to purchase all 371,092 shares subject to the option, subject to the same vesting schedule as the original option. As of December 31, 2023, 7,731 unvested shares of restricted stock remain outstanding under this option award. (7) This option vests 25% on June 22, 2022, with the remaining 75% vesting in 36 equal monthly installments, subject generally to the NEO’s continued employment with us. (8) This option vests 25% on January 25, 2023, with the